Palbociclib and Letrozole in Advanced Breast CancerRichard S. Finn, Dennis J. Slamon, Miguel Martín et al.|New England Journal of Medicine|2016Cited by 2.9k
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant stateGloria V. Echeverria, Helen Piwnica‐Worms, Zhongqi Ge et al.|Science Translational Medicine|2019Cited by 316
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 studyErica L. Mayer, Michael Gnant, M. Bellet-Ezquerra et al.|The Lancet Oncology|2021Cited by 255
High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancerGloria V. Echeverria, Helen Piwnica‐Worms, Emily Powell et al.|Nature Communications|2018Cited by 149
Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancerReid T. Powell, Helen Piwnica‐Worms, Abena B. Redwood et al.|Scientific Reports|2020Cited by 22